Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galapagos NV (NASDAQ:GLPG)

60.65
Delayed Data
As of Jul 31
 +3.60 / +6.31%
Today’s Change
12.91
Today|||52-Week Range
63.33
+227.66%
Year-to-Date
No recent news for Galapagos NV.

Today’s Trading

Previous close57.05
Today’s open59.83
Day’s range59.77 - 63.33
Volume64,896
Average volume (3 months)87,272
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-304.48%
Earnings growth (this year)--
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)-49.96%
P/E ratio--
Price/Sales6.16
Price/Book6.77

Competitors

 Today’s
change
Today’s
% change
LGNDLigand Pharmaceutica...+0.48+0.45%
LCILannett Company Inc+0.16+0.27%
SAGESAGE Therapeutics In...+0.60+0.89%
ALDRAlder Biopharmaceuti...+0.17+0.37%
Data as of 4:01pm ET, 07/31/2015

Financials

Next reporting dateAugust 7, 2015
EPS forecast (this quarter)-$0.51
Annual revenue (last year)$91.7M
Annual profit (last year)-$45.3M
Net profit margin-53.78%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
Onno van de Stolpe
Chief Financial Officer
Bart Filius
Corporate headquarters
Mechelen, Brussels Region

Forecasts